Total plasma homocysteine: The mediator/marker controversy continues

Clinical Chemistry

Volumn 55, Issue 9, 2009, Pages 1742-1743

  Jacobsen, D W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HOMOCYSTEINE;

BLOOD LEVEL; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CYANOCOBALAMIN DEFICIENCY; DISEASE SEVERITY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; METHYLMALONIC ACIDEMIA; NOTE;

AUTOBIOGRAPHY; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HISTORY, 20TH CENTURY; HOMOCYSTEINE; HUMANS;

EID: 69549108766     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.128744     Document Type: Note

References (6)

1. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-128
2. Ueland PM. Citation classic: importance of chemical reduction in plasma and serum homocysteine analysis. Clin Chem 2008;54:1085-1086
3. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, et al. Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation 1995;92:2825-2830
4. Robinson K, Gupta A, Dennis V, Arheart K, Chaudhary D, Green R, et al. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996;94:2743-2748 (Pubitemid 26411737)
5. Gupta A, Moustapha A, Jacobsen DW, Goormastic M, Tuzcu EM, Hobbs R, et al. High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients. Transplantation 1998;65:544-550
6. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995;41:991-994